Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Cell-Surface Marker Signature for Enrichment of Ventricular Cardiomyocytes Derived from Human Embryonic Stem Cells.

Veevers J, Farah EN, Corselli M, Witty AD, Palomares K, Vidal JG, Emre N, Carson CT, Ouyang K, Liu C, van Vliet P, Zhu M, Hegarty JM, Deacon DC, Grinstein JD, Dirschinger RJ, Frazer KA, Adler ED, Knowlton KU, Chi NC, Martin JC, Chen J, Evans SM.

Stem Cell Reports. 2018 Sep 11;11(3):828-841. doi: 10.1016/j.stemcr.2018.07.007. Epub 2018 Aug 16.

2.

Quantitative cardiovascular magnetic resonance: extracellular volume, native T1 and 18F-FDG PET/CMR imaging in patients after revascularized myocardial infarction and association with markers of myocardial damage and systemic inflammation.

Kunze KP, Dirschinger RJ, Kossmann H, Hanus F, Ibrahim T, Laugwitz KL, Schwaiger M, Rischpler C, Nekolla SG.

J Cardiovasc Magn Reson. 2018 May 24;20(1):33. doi: 10.1186/s12968-018-0454-y.

3.

Interplay of cell-cell contacts and RhoA/MRTF-A signaling regulates cardiomyocyte identity.

Dorn T, Kornherr J, Parrotta EI, Zawada D, Ayetey H, Santamaria G, Iop L, Mastantuono E, Sinnecker D, Goedel A, Dirschinger RJ, My I, Laue S, Bozoglu T, Baarlink C, Ziegler T, Graf E, Hinkel R, Cuda G, Kääb S, Grace AA, Grosse R, Kupatt C, Meitinger T, Smith AG, Laugwitz KL, Moretti A.

EMBO J. 2018 Jun 15;37(12). pii: e98133. doi: 10.15252/embj.201798133. Epub 2018 May 15.

4.

Probing chromatin landscape reveals roles of endocardial TBX20 in septation.

Boogerd CJ, Aneas I, Sakabe N, Dirschinger RJ, Cheng QJ, Zhou B, Chen J, Nobrega MA, Evans SM.

J Clin Invest. 2016 Aug 1;126(8):3023-35. doi: 10.1172/JCI85350. Epub 2016 Jun 27.

5.

Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.

Rischpler C, Dirschinger RJ, Nekolla SG, Kossmann H, Nicolosi S, Hanus F, van Marwick S, Kunze KP, Meinicke A, Götze K, Kastrati A, Langwieser N, Ibrahim T, Nahrendorf M, Schwaiger M, Laugwitz KL.

Circ Cardiovasc Imaging. 2016 Apr;9(4):e004316. doi: 10.1161/CIRCIMAGING.115.004316.

6.

Upregulated myocardial CXCR4-expression after myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI.

Rischpler C, Nekolla SG, Kossmann H, Dirschinger RJ, Schottelius M, Hyafil F, Wester HJ, Laugwitz KL, Schwaiger M.

J Nucl Cardiol. 2016 Feb;23(1):131-3. doi: 10.1007/s12350-015-0347-5. Epub 2015 Dec 14. No abstract available.

PMID:
26667813
7.

Combination of factor Xa inhibition and antiplatelet therapy after stenting in patients with iliofemoral post-thrombotic venous obstruction.

Langwieser N, Bernlochner I, Wustrow I, Dirschinger RJ, Jaitner J, Dommasch M, Bradaric C, Laugwitz KL, Ibrahim T.

Phlebology. 2016 Jul;31(6):430-7. doi: 10.1177/0268355515596289. Epub 2015 Jul 15.

PMID:
26183668
8.

Postextrasystolic blood pressure potentiation predicts poor outcome of cardiac patients.

Sinnecker D, Dirschinger RJ, Barthel P, Müller A, Morley-Davies A, Hapfelmeier A, Dommasch M, Huster KM, Hasenfuss G, Laugwitz KL, Malik M, Schmidt G.

J Am Heart Assoc. 2014 Jun 3;3(3):e000857. doi: 10.1161/JAHA.114.000857.

9.

Assessment of mean respiratory rate from ECG recordings for risk stratification after myocardial infarction.

Sinnecker D, Dommasch M, Barthel P, Müller A, Dirschinger RJ, Hapfelmeier A, Huster KM, Laugwitz KL, Malik M, Schmidt G.

J Electrocardiol. 2014 Sep-Oct;47(5):700-4. doi: 10.1016/j.jelectrocard.2014.04.021. Epub 2014 May 4.

PMID:
24891267
10.

Cell labeling and injection in developing embryonic mouse hearts.

Hiriart E, van Vliet P, Dirschinger RJ, Evans SM, Puceat M.

J Vis Exp. 2014 Apr 17;(86). doi: 10.3791/51356.

11.

Nocturnal respiratory rate predicts non-sudden cardiac death in survivors of acute myocardial infarction.

Dommasch M, Sinnecker D, Barthel P, Müller A, Dirschinger RJ, Hapfelmeier A, Huster KM, Laugwitz KL, Malik M, Schmidt G.

J Am Coll Cardiol. 2014 Jun 10;63(22):2432-3. doi: 10.1016/j.jacc.2014.02.525. Epub 2014 Mar 5. No abstract available.

12.

Modeling long-QT syndromes with iPS cells.

Sinnecker D, Goedel A, Dorn T, Dirschinger RJ, Moretti A, Laugwitz KL.

J Cardiovasc Transl Res. 2013 Feb;6(1):31-6. doi: 10.1007/s12265-012-9416-1. Epub 2012 Oct 18. Review.

PMID:
23076501
13.

Induced pluripotent stem cells in cardiovascular research.

Sinnecker D, Dirschinger RJ, Goedel A, Moretti A, Lipp P, Laugwitz KL.

Rev Physiol Biochem Pharmacol. 2012;163:1-26. doi: 10.1007/112_2012_6. Review.

PMID:
22447279
14.

Recapitulating long-QT syndrome using induced pluripotent stem cell technology.

Dirschinger RJ, Goedel A, Moretti A, Laugwitz KL, Sinnecker D.

Pediatr Cardiol. 2012 Aug;33(6):950-8. doi: 10.1007/s00246-012-0286-8. Epub 2012 Mar 13.

PMID:
22411718
15.

Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia.

Jung CB, Moretti A, Mederos y Schnitzler M, Iop L, Storch U, Bellin M, Dorn T, Ruppenthal S, Pfeiffer S, Goedel A, Dirschinger RJ, Seyfarth M, Lam JT, Sinnecker D, Gudermann T, Lipp P, Laugwitz KL.

EMBO Mol Med. 2012 Mar;4(3):180-91. doi: 10.1002/emmm.201100194. Epub 2012 Jan 25.

16.

Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function.

Shen T, Aneas I, Sakabe N, Dirschinger RJ, Wang G, Smemo S, Westlund JM, Cheng H, Dalton N, Gu Y, Boogerd CJ, Cai CL, Peterson K, Chen J, Nobrega MA, Evans SM.

J Clin Invest. 2011 Dec;121(12):4640-54. doi: 10.1172/JCI59472. Epub 2011 Nov 14.

17.

The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3.

Spiekermann K, Dirschinger RJ, Schwab R, Bagrintseva K, Faber F, Buske C, Schnittger S, Kelly LM, Gilliland DG, Hiddemann W.

Blood. 2003 Feb 15;101(4):1494-504. Epub 2002 Oct 24.

Supplemental Content

Loading ...
Support Center